TGF-β: the master regulator of fibrosis

X Meng, DJ Nikolic-Paterson, HY Lan - Nature Reviews Nephrology, 2016 - nature.com
Transforming growth factor-β (TGF-β) is the primary factor that drives fibrosis in most, if not
all, forms of chronic kidney disease (CKD). Inhibition of the TGF-β isoform, TGF-β1, or its …

Non-canonical (non-SMAD2/3) TGF-β signaling in fibrosis: Mechanisms and targets

KW Finnson, Y Almadani, A Philip - Seminars in cell & developmental …, 2020 - Elsevier
Transforming growth factor (TGF)-β uses several intracellular signaling pathways besides
canonical ALK5-Smad2/3 signaling to regulate a diverse array of cellular functions. Several …

KLF 4 is a key determinant in the development and progression of cerebral cavernous malformations

R Cuttano, N Rudini, L Bravi, M Corada… - EMBO molecular …, 2016 - embopress.org
Cerebral cavernous malformations (CCM s) are vascular malformations located within the
central nervous system often resulting in cerebral hemorrhage. Pharmacological treatment is …

Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness

DFG Remst, EN Blaney Davidson… - …, 2015 - academic.oup.com
Synovial fibrosis is often found in OA, contributing heavily to joint pain and joint stiffness, the
main symptoms of OA. At this moment the underlying mechanism of OA-related synovial …

Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8) 9 …

D Wnuk, M Paw, K Ryczek, G Bochenek, K Sładek… - Scientific reports, 2020 - nature.com
Airway remodelling with subepithelial fibrosis, which abolishes the physiological functions of
the bronchial wall, is a major issue in bronchial asthma. Human bronchial fibroblasts (HBFs) …

Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis

T Luangmonkong, S Suriguga… - British Journal of …, 2017 - Wiley Online Library
Background and Purpose Liver fibrosis is a major cause of liver‐related mortality and, so far,
no effective antifibrotic drug is available. Galunisertib, a TGF‐β receptor type I kinase …

Endothelial loss of ETS1 impairs coronary vascular development and leads to ventricular non-compaction

L Wang, L Lin, H Qi, J Chen, P Grossfeld - Circulation research, 2022 - Am Heart Assoc
Rationale: Jacobsen syndrome is a rare chromosomal disorder caused by deletions in the
long arm of human chromosome 11, resulting in multiple developmental defects including …

Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome

M Vicen, IC Igreja Sá, K Tripská, B Vitverová… - Cellular and Molecular …, 2021 - Springer
Abstract Membrane endoglin (Eng, CD105) is a transmembrane glycoprotein essential for
the proper function of vascular endothelium. It might be cleaved by matrix …

TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

JM Munoz-Felix, M Gonzalez-Nunez… - Pharmacology & …, 2015 - Elsevier
The understanding of renal fibrosis in chronic kidney disease (CKD) remains as a challenge.
More than 10% of the population of developed countries suffer from CKD. Proliferation and …

[HTML][HTML] MicroRNA-26a-5p restoration ameliorates unilateral ureteral obstruction-induced renal fibrosis in mice through modulating TGF-β signaling

YH Chung, GK Huang, CH Kang, YT Cheng… - Laboratory …, 2023 - Elsevier
Renal fibrosis is a hallmark of chronic and progressive renal diseases characterized by
excessive fibroblast proliferation, extracellular matrix accumulation, and a loss of renal …